SEC-sourced researchBeta
IMCR
Immunocore Holdings plc
Company comparison ↗
Data passport
- CIK
- 0001671927
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Sep 14, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 249,428,000.0000 | Feb 25, 2026 |
| December 2024 | 310,202,000.0000 | Feb 25, 2026 |
| December 2025 | 400,016,000.0000 | Feb 25, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 400,016,000.0000 | -35,514,000.0000 | -10,712,000.0000 | 1,067,269,000.0000 | 686,236,000.0000 | Feb 25, 2026 |
| December 2024 | 310,202,000.0000 | -51,087,000.0000 | 26,061,000.0000 | 1,009,506,000.0000 | 648,790,000.0000 | Feb 25, 2026 |
| December 2023 | 249,428,000.0000 | -55,287,000.0000 | 2,940,000.0000 | — | — | Feb 25, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $400.02M | December 2025 | Feb 25, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $310.2M | December 2024 | Feb 25, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$35.51M | December 2025 | Feb 25, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$10.71M | December 2025 | Feb 25, 2026 | 10-K |
| Total assetsAssets | $1.07B | December 2025 | Feb 25, 2026 | 10-K |
| Total liabilitiesLiabilities | $686.24M | December 2025 | Feb 25, 2026 | 10-K |